Search research articles
Contact Us
Filters
Showing results (31-40 of 393) with videos related to
Page
of 40
Sort By:
Cancer Treatment Reviews
|
November 1, 1996
Brachytherapy in the management of breast cancer: a review
B R Pieters, M Maher, A L Gerbaulet
Oncogene
|
February 26, 2013
Myocyte enhancer factor 2C in hematopoiesis and leukemia
K Canté-Barrett, R Pieters, J P P Meijerink
Journal of Contemporary Brachytherapy
|
March 20, 2020
A history of transurethral resection of the prostate should not be a contra-indication for low-dose-rate <sup>125</sup>I prostate brachytherapy: results of a prospective Uro-GEC phase-II trial
Carl Salembier, Ann Henry, Bradley R Pieters, et al.
Expert Review of Anticancer Therapy
|
August 9, 2017
Improving postoperative radiotherapy following radical prostatectomy
D Lipman, B R Pieters, Theo M De Reijke
Blood
|
July 13, 2000
Biological and therapeutic aspects of infant leukemia
A Biondi, G Cimino, R Pieters, et al.
Leukemia
|
November 21, 1998
Mechanisms of cellular anthracycline resistance in childhood acute leukemia
M L Den Boer, R Pieters, A J Veerman
The Journal of Urology
|
November 13, 2012
Re: does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis
B R Pieters, C C E Koning, S Horenblas
Leukemia
|
July 28, 2012
The hunting of targets: challenge in miRNA research
F Akbari Moqadam, R Pieters, M L den Boer
Advances in Experimental Medicine and Biology
|
January 1, 1989
Sensitivity to purine analogues in childhood leukemia assessed by the automated MTT-assay
R Pieters, D R Huismans, A Leyva, et al.
Medical and Pediatric Oncology
|
December 1, 1995
High-dose-rate brachytherapy in childhood sarcomas: a local control strategy preserving bone growth and function
S Nag, T Olson, F Ruymann, et al.
Page
of 40
Search research articles
Search
Showing results (31-40 of 393) with videos related to
Sort By:
Page
of 40
Cancer Treatment Reviews
|
November 1, 1996
Brachytherapy in the management of breast cancer: a review
B R Pieters, M Maher, A L Gerbaulet
Oncogene
|
February 26, 2013
Myocyte enhancer factor 2C in hematopoiesis and leukemia
K Canté-Barrett, R Pieters, J P P Meijerink
Journal of Contemporary Brachytherapy
|
March 20, 2020
A history of transurethral resection of the prostate should not be a contra-indication for low-dose-rate <sup>125</sup>I prostate brachytherapy: results of a prospective Uro-GEC phase-II trial
Carl Salembier, Ann Henry, Bradley R Pieters, et al.
Expert Review of Anticancer Therapy
|
August 9, 2017
Improving postoperative radiotherapy following radical prostatectomy
D Lipman, B R Pieters, Theo M De Reijke
Blood
|
July 13, 2000
Biological and therapeutic aspects of infant leukemia
A Biondi, G Cimino, R Pieters, et al.
Leukemia
|
November 21, 1998
Mechanisms of cellular anthracycline resistance in childhood acute leukemia
M L Den Boer, R Pieters, A J Veerman
The Journal of Urology
|
November 13, 2012
Re: does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis
B R Pieters, C C E Koning, S Horenblas
Leukemia
|
July 28, 2012
The hunting of targets: challenge in miRNA research
F Akbari Moqadam, R Pieters, M L den Boer
Advances in Experimental Medicine and Biology
|
January 1, 1989
Sensitivity to purine analogues in childhood leukemia assessed by the automated MTT-assay
R Pieters, D R Huismans, A Leyva, et al.
Medical and Pediatric Oncology
|
December 1, 1995
High-dose-rate brachytherapy in childhood sarcomas: a local control strategy preserving bone growth and function
S Nag, T Olson, F Ruymann, et al.
Page
of 40